Drug Pricing Reforms To Underwrite Major Part Of Senate ‘Soft’ Infrastructure Legislation

Senate Finance Committee directed to provide ‘nearly all’ of the spending offsets for the $3.5tn package; Committee chair Ron Wyden is focused on authorizing the US government to directly negotiate drug prices in Medicare.

Senate Finance Committee Chairman Ron Wyden, D-OR. • Source: Alamy

US government price negotiation and price inflation rebates for prescription drugs in Medicare are two major revenue generators that Senate Democrats are counting on to fund a significant part of their $3.5tn so-called “soft” infrastructure legislation, according to a budget resolution plan released by Senate leaders 9 August.

The plan lays out a path for the Senate to pass the infrastructure provisions without Republican support as part of a broader budget reconciliation bill. The infrastructure provisions include expansion...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Legislation

More from Pink Sheet